Idarubicin [clinicaltrials_resource:81136dffc99fb67581ffca7183bcb20e]
inclusion criteria [clinicaltrials_vocabulary:inclusion-criteria]
Combination Chemotherapy in Treating Patients With Intermediate-Grade or Immunoblastic Non-Hodgkin's Lymphoma [clinicaltrials:NCT00002565]Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Promyelocytic Leukemia [clinicaltrials:NCT00002701]Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myelogenous Leukemia or Myelodysplastic Syndrome [clinicaltrials:NCT00002798]Chemotherapy in Treating Patients With Newly Diagnosed Acute or Chronic Myelogenous Leukemia or Myelodysplastic Syndrome [clinicaltrials:NCT00002800]clinicaltrials:NCT00002812clinicaltrials:NCT00002816clinicaltrials:NCT00002833High Dose Chemotherapy, Peripheral Stem Cell Transplantation, and Interleukin-2 in Treating Patients With Acute Myeloid Leukemia [clinicaltrials:NCT00002945]Combination Chemotherapy With or Without Idarubicin and Peripheral Stem Cell Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome [clinicaltrials:NCT00002989]clinicaltrials:NCT00003178Amifostine and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia [clinicaltrials:NCT00003268]Combination Chemotherapy Plus Biological Therapy in Treating Patients With Acute Myelogenous Leukemia [clinicaltrials:NCT00003405]Combination Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia [clinicaltrials:NCT00003602]Chemotherapy Plus Steroid Therapy in Treating Patients With Multiple Myeloma [clinicaltrials:NCT00003603]Combination Chemotherapy With or Without Interferon Alfa in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma [clinicaltrials:NCT00003639]Combination Chemotherapy in Treating Children With Relapsed or Refractory Acute Lymphocytic Leukemia [clinicaltrials:NCT00003729]Combination Chemotherapy in Treating Patients With Relapsed Acute Myelogenous Leukemia [clinicaltrials:NCT00003758]clinicaltrials:NCT00003783Bevacizumab, Idarubicin, and Cytarabine in Treating Patients With Blast Phase Chronic Myelogenous Leukemia [clinicaltrials:NCT00023920]clinicaltrials:NCT00067028clinicaltrials:NCT00074737Idarubicin, Cytarabine, and Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome [clinicaltrials:NCT00077116]Study Evaluating the Addition of Amifostine (Ethyol®) to Idarubicin and Cytosine Arabinoside in Older Patients With Acute Myeloid Leukemia [clinicaltrials:NCT00086099]clinicaltrials:NCT00093483clinicaltrials:NCT00096122Idarubicin and Cytarabine With or Without Bevacizumab in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia [clinicaltrials:NCT00096148]Pravastatin, Idarubicin, and Cytarabine in Treating Patients With Acute Myeloid Leukemia [clinicaltrials:NCT00107523]clinicaltrials:NCT00111345Thalidomide, Cyclophosphamide, Oral Idarubicin and Dexamethasone (T-CID) in Patients With Multiple Myeloma [clinicaltrials:NCT00124813]clinicaltrials:NCT00193973Salvage Therapy With Idarubicin in Relapsing CNS Lymphoma [clinicaltrials:NCT00210366]Vorinostat and Idarubicin in Treating Patients With Relapsed or Refractory Leukemia or Myelodysplastic Syndromes [clinicaltrials:NCT00331513]clinicaltrials:NCT00382954All-trans Retinoic Acid, and Arsenic +/- Gemtuzumab [clinicaltrials:NCT00413166]clinicaltrials:NCT00422591clinicaltrials:NCT00469859clinicaltrials:NCT00482833VELCADE in Combination With Idarubicin and Cytosine Arabinoside in Patients With Acute Myelogenous Leukemia [clinicaltrials:NCT00505700]clinicaltrials:NCT00528398clinicaltrials:NCT00528450
intervention browse [clinicaltrials_vocabulary:intervention-browse]
Idarubicin [clinicaltrials_resource:81136dffc99fb67581ffca7183bcb20e]
Bio2RDF identifier
81136dffc99fb67581ffca7183bcb20e
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:81136dffc99fb67581ffca7183bcb20e
identifier
clinicaltrials_resource:81136dffc99fb67581ffca7183bcb20e
title
Idarubicin
@en
type
label
Idarubicin [clinicaltrials_resource:81136dffc99fb67581ffca7183bcb20e]
@en